Quantitative Imaging Apoe4 Effects On Brain Tau Deposition And Glucose Metabolism In Mild Cognitive Impairment Patients With [F-18]Av1451 And [F-18]Fdg Pet
Min Liu,Xueqi Chen,Manish Paranjpe,Qian Zhao,Jeffrey Leal,Rongfu Wang,Gwenn Smith,Martin Pomper,Dean Wong,Yun Zhou
2018-01-01
Journal of Nuclear Medicine
Abstract:80 Objectives: APOE4 is identified to be a high risk factor for late-onset Alzheimer Disease. Our objective is to study the APOE4 effects on brain tau deposition and glucose metabolism in mild cognition impairment (MCI) patients using quantitative [18F]AV1451 and [18F]FDG PET. Methods: [18F]AV1451 tau PET scans for 63 (24 subjects of APOE4) MCI patients and longitudinal [18F]FDG PET scans over a 96-month period in 48 (24 subjects of APOE4) MCI patients , as well as MRIs, and demographic information, were downloaded from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database. The downloaded preprocessed PET images were aligned, averaged, reoriented and then interpolated into a standard image and voxel size (image volume 160×160×96, 1.5x1.5x1.5 mm in x, y, z), and smoothed to a uniform resolution of 8 mm in full width at half maximum (FWHM). The structural MRIs were used for PET spatial normalization and region of interest (ROI) definition in standard space. An iterative reblurred Van Cittertiteration method was used for partial volume correction (PVC) on the all PET images [1], where a 3-D Gaussian kernel of 8 mm FWHM was used for spatial smoothing function h, step length α=1.5, and the iteration was stopped if relative percent change of PVC images < 1%. Regions of interest (ROIs) including cerebellum gray matter for reference tissue were manually drawn on the MRI template using PMOD software (PMOD Technologies Ltd., Zurich, Switzerland) in standard MNI space. Standard uptake value ratio (SUVR) images relative to the cerebellum ROI were calculated in the MNI space. ROI SUVRs were obtained by applying ROIs to SUVR images. A statistical software SAS was used for all statistical analysis. A general linear model was used to evaluate APOE4 effects on ROI SUVRs with adjustments of gender, age, and education level. For evaluation of PVC effects on our results, all ROI SUVRs from non-partial volume corrected (nonPVC) PET images were also analyzed. Results: Based PVC PET images, the parietal, medial temporal, lateral temporal, amygdala, hippocampus, caudate, thalamus, and post-cingulate regions had greater longitudinal decreases in [18F]FDG uptake in the APOE4 carriers compared to non-carriers in patients with MCI (p<0.03). In [18F]AV1451 tau PET study, the medial temporal, anterior cingulate, Amygdala, fusiform, parahipocampus, putamen, and ventral Striatum showed significant higher SUVR in the APOE4 carriers compared to non-APOE4 carriers (p<0.02). The statistical levels were reduced in non-PVC based ROI SUVR comparison. Specifically, in [18F]FDG PET study, we observe a near but not significant APOE4-mediated effect in FDG uptake in the amgydala, posterior cingulate, and the hippocampus (p= 0.14, 0.10, and 0.07 for amgydala, posterior cingulate, and the hippocampus, respectively) without PVC . The p value was reduced to 0.053 for ventral striatum in nonPVC [18F]AV1451 tau PET study. Conclusions: The study identified APOE4 correlates with brain regions that were associated with decline in glucose uptake over time and increased tau deposition. Partial volume correction is suggested for AD study with quantitative [18F]AV1451 or longitudinal [18F]FDG PET .
Reference
[1] Jussi Tohkaa, Anthonin Reilhac. NeuroImage. 2008; 39:1570-1584.